Business Context and Reporting Period
Company: Ecolab Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2002
Business Overview: Ecolab provides cleaning, sanitizing, and pest control products and services. The reporting period is significantly impacted by the full consolidation of the Henkel-Ecolab joint venture (acquired at year-end 2001), the adoption of SFAS No. 142 (Goodwill), and major restructuring initiatives in European operations.
Key Financial Metrics
| Metric | Q1 2002 | Q1 2001 | Change |
|---|---|---|---|
| Net Sales | $786.1 million | $571.4 million | +38% |
| Operating Income | $72.9 million | $77.4 million | -6% |
| Net Income | $38.9 million | $44.4 million | -12% |
| Diluted EPS | $0.30 | $0.34 | -12% |
| Cash from Operations | $86.8 million | $54.0 million | +61% |
| Total Debt | $717.0 million | $746.0 million (Year-end 2001) | -4% |
| Cash & Equivalents | $30.2 million | $41.8 million (Year-end 2001) | -28% |
Margins: Gross profit margin was 49.6% (down from 52.3% in Q1 2001), impacted by restructuring charges and the inclusion of lower-margin European operations. Operating margin was 9.3% compared to 13.5% in the prior year.
Material Changes vs. Prior Period
- Revenue Growth: The 38% sales increase is primarily driven by the consolidation of Henkel-Ecolab. Organic growth (excluding acquisitions) was approximately 2%.
- Restructuring Charges: The company recorded $23.3 million in pretax restructuring and special charges in Q1 2002, primarily related to European integration, workforce reductions (approx. 275 employees), and facility closures. This reduced net income by $0.11 per diluted share.
- Accounting Changes: Adoption of SFAS No. 142 eliminated goodwill amortization, increasing net income by approximately $7.2 million ($0.06 per share) compared to prior year methodology. Reclassification of customer incentive costs (EITF 01-09) reduced reported revenue by $9.5 million in the prior year for comparability.
- Discontinued Operations: A one-time gain of $1.9 million was recognized from the resolution of a legal issue regarding the 1992 disposal of the Chemlawn business.
- Interest Expense: Net interest expense rose 58% to $10.5 million due to higher debt levels incurred to finance the Henkel-Ecolab acquisition.
Guidance, Outlook, and Risks
- Restructuring Outlook: Management anticipates total pretax restructuring charges of $50 million to $60 million for the full year 2002. These actions are expected to yield annual pretax savings of $25 million to $30 million, with full impact realized in 2003.
- Benefit Plan Changes: A curtailment gain of $5.8 million was recorded in Q1 2002 due to changes in employee benefit plans. This is expected to result in approximately $16 million of net unrealized gains amortized over 8 years, reducing future benefit costs.
- Pro Forma Performance: Excluding special charges, discontinued operations, and accounting changes, diluted income from ongoing operations was $0.37 per share, matching the pro forma result for Q1 2001.
- Risks: Key risks include foreign currency exposure (increased due to Henkel-Ecolab consolidation), raw material price volatility, competitive pricing pressures, and the ability to achieve projected cost savings from restructuring.
Investor Verification Checklist
- Restructuring Execution: Verify the timeline and actual cost savings realized from the announced $50-$60 million restructuring plan.
- European Integration: Monitor the performance of the newly consolidated European operations (Henkel-Ecolab) and their impact on overall gross margins.
- Debt Management: Track the company's ability to reduce total debt levels, which currently stand at $717 million with a debt-to-capitalization ratio of 44%.
- Goodwill Impairment: Review future filings for results of goodwill impairment testing required under SFAS No. 142.
- Organic Growth: Distinguish between acquisition-driven revenue growth and organic sales growth, which was reported at only 2% for the quarter.